Vascular manifestations in giant-cell arteritis

Vascular Manifestations of Systemic Autoimmune Diseases

Volumn , Issue , 2001, Pages 237-250

  Cid, Maria C ^a   Hernandez Rodriguez J ^a   Grau, Josep M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002316814     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (47)

1. Hunder, GG, Giant-cell arteritis and polymyalgia rheumatica, Med. Clin. North. Am., 1997;81:195-219
2. Cid, MC, Large vessel vasculitides, Curr. Opin. Rheumatol., 1998;10:18-28.
3. Baldursson, O, Steinsson, K, Bjornsson, J, Giant-cell arteritis in Iceland: an epidemiologic and histologic analysis, Arthritis Rheum., 1994;37:1007-1012.
4. Noltorp, S, Svensson, B, High incidence of polymyalgia rheumatica and giant-cell arteritis in a Swedish community, Clin. Exp. Rheumatol., 1991;9:351-354.
5. Nordborg, E, Bengtsson, BA, Epidemiology of biopsy-proven giant-cell arteritis, J. Intern. Med., 1990;227:233-236.
6. Salvarani, C, Gabriel, SE, O’Fallon, WM, Hunder, GG, The incidence of giant-cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern, Ann. Intern. Med., 1995;123:192-194.
7. González-Gay, MA, Alonso, MD, Agüero, JJ, Bal, M, Fernámdez-Camblor, B, Sánchez-Andrade, A, Temporal arteritis in a Northwestern area of Spain: study of 57 biopsy-proven patients, J. Rheumatol., 1992;19:277-280.
8. Sonnenblick, M, Nesher, G, Friedlander, Y, Rubinow, A, Giant-cell arteritis in Jerusalem: a 12-year epidemiological study, Br. J. Rheumatol., 1994;33:938-941.
9. Lie, JT, Histopathologic specificity of systemic vasculitis, Rheum. Dis. Clin. North Am., 1995;21:883-909.
10. Ostberg, G, Morphological changes in the large arteries in polymyalgia arteritica, Acta Med. Scand., 1972;533:135-164.
11. Klein, RG, Hunder, GG, Stanson, AW, Sheps SG, Large artery involvement in giant-cell (temporal) arteritis, Ann. Intern. Med., 1975;83:806-812.
12. Evans, JM, O’Fallon, WM, Hunder, GG, Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis, Ann. Intern. Med., 1995;122:502-507.
13. Meliconi, R, Pulsatelli, L, Uguccioni, M, Salvarani, C, Macchioni, P, Melchiorri, C, Focherini, C, Frizziero, L, Facchini, A, Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica: quantitative analysis and influence of corticosteroid treatment, Arthritis Rheum., 1996;39:1199-1207.
14. Meliconi, R, Pulsatelli, L, Melchiorri, C, Frizziero, L, Salvarani, C, Macchioni, P, Uguccioni, M, Focherini, MC, Facchini, A, Synovial expression of cell adhesion molecules in polymyalgia rheumatica, Clin. Exp. Immunol., 1997;107:494-500.
15. Bignon, JD, Barrier, J, Soulillou, JP, Martin, PH, Grolleau, JY, HLA-DR4 and giant-cell arteritis, Tissue Antigens, 1984;24:60-62.
16. Cid, MC, Ercilla, MG, Vilaseca, J, Sanmartí, J, Villalta, J, Ingelmo, M, Urbano-Márquez, A, Polymyalgia rheumatica: a syndrome associated with the HLA-DR4 antigen, Arthritis Rheum., 1988;31:678-682.
17. Weyand, CM, Hicok, KC, Hunder, GG, Goronzy, JJ, The HLA-DRB1 locus as a genetic component in giant cell arteritis: mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule, J. Clin. Invest., 1992;90:2355-2361.
18. Cid, MC, Campo, E, Ercilla, G, Palacín, A, Vilaseca, J, Villalta, J, Ingelmo, M, Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis, Arthritis Rheum., 1989;32:884-893.
19. Weyand, CM, Hicok, KC, Hunder, GG, Goronzy, JJ, Tissue cytokine patterns in patients with polymyalgia rheumatica and giant-cell arteritis, Ann. Intern. Med., 1994;121:484-491.
20. Weyand, CM, Tetzlaff, N, Björnsson, J, Brack, A, Younge, B, Goronzy, JJ, Disease patterns and tissue cytokine profiles in giant cell arteritis, Arthritis Rheum., 1997;40:19-26.
21. Weyand, CM, Shonberger, J, Oppitz, U, Hunder, NNH, Hicok, KC, Goronzy, JJ, Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes, J. Exp. Med., 1994;179:951-960.
22. Gabriel, S, Espy, M, Erdman, D, Björnsson, J, Smith, TF, Hunder, GG, The role of parvovirus B19 in the pathogenesis of giant-cell arteritis. A preliminary evaluation, Arthritis Rheum., 1999;42:1255-1258.
23. Weyand, CM, Goronzy, JJ, Arterial wall injury in giant cell arteritis, Arthritis Rheum., 1999;42:844-853.
24. Font, C, Cebrián, M, Cid, MC, Coll-Vinent, B, Sánchez, E, López-Soto, A, Grau, JM, Polymorphonuclear leukocytes and E-selectin expression in inflammatory lesions of giant cell arteritis, Arthritis Rheum., 1996;39 (suppl): S67.
25. Cid, MC, Cebrián, M, Font, C, Coll-Vinent, B, Hernández-Rodríguez, J, Esparza, J, Urbano-Márquez, A, Grau, JM, Cell adhesion molecules in the development of inflammatory infiltrates in giant-cell arteritis. Inflammation-induced angiogenesis as the preferential site of leukocyte/endothelial cell interactions, Arthritis Rheum., 2000;43:184-194.
26. Cid, MC, New developments in the pathogenesis of systemic vasculitis, Curr. Opin. Rheumatol., 1996;8:1-11.
27. Kaiser, M, Weyand, CM, Björnsson, J, Goronzy, JJ, Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis, Arthritis Rheum., 1998;41:623-633.
28. Huston, KA, Hunder, GG, Lie, JT, Kennedy, RH, Elveback, LR, Temporal arteritis. A 25-year epidemiological, clinical and pathologic study, Ann. Intern. Med., 1978;88:162-167.
29. Calamia, KT, Hunder, GG, Clinical manifestations of giant cell arteritis, Clin. Rheum. Dis., 1980;6:389-403.
30. Hayreh, SS, Podhajsky, PA, Zimmerman, B, Ocular manifestations of giant cell arteritis, Am. J. Ophthalmol., 1988;125:509-520.
31. Cid, MC, Font, C, Oristrell, J, de la Sierra, A, Coll-Vinent, B, López-Soto, A, Vilaseca, J, Urbano-Márquez, A, Grau, JM, Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis, Arhritis Rheum., 1998;41:26-32.
32. Chuang, TY, Hunder, GG, Ilstrup, DM, Kurland, LT, Polymyalgia rheumatica: a 10-year epidemiologic and clinical study, Ann. Intern. Med., 1982;97:672-680.
33. Salvarani, C, Macchioni, P, Boiardi, L, Polymyalgia rheumatica, Lancet, 1997;350:43-47.
34. Salvarani, C, Hunder, GG, Musculoskeletal manifestations in a population-based cohort of patients with giant-cell arteritis, Arthritis Rheum., 1999;42:1259-1266.
35. Salvarani, C, Cantini, F, Macchioni, P, Olivieri, I, Niccoli, L, Padula, A, Boiardi, L, Distal musculoskeletal manifestations in polymyalgia rheumatica, Arthritis Rheum., 1998;41:1221-1226.
36. Roche, EN, Fullbright, JW, Wagner, A, Hunder, GG, Goronzy, JJ, Weyand, CM, Correlation between interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis, Arthritis Rheum., 1993;36:1286-1294.
37. Coll-Vinent, B, Vilardell, C, Font, C, Oristrell, J, Hernández-Rodríguez, J, Yagüe, J, Urbano-Márquez, A, Grau, JM, Cid, MC, Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (ICAM-1) concentrations and disease activity, Ann Rheum. Dis., 1999;58:189-192.
38. Cid, MC, Monteagudo, J, Oristrell, J, Vilaseca, J, Pallarés, L, Cervera, R, Font, C, Font, J, Ingelmo, M, Urbano-Márquez, A, Von Willebrand factor in the outcome of temporal arteritis, Ann. Rheum. Dis., 1996;55:927-930.
39. Vilaseca, J, González, A, Cid, MC, López-Vivancos, J, Ortega, A, Clinical usefulness of temporal artery biopsy, Ann. Rheum. Dis., 1987;46:282-285.
40. Cid, MC, Campo, E, Diagnostic value of the temporal artery biopsy, Med. Clin. (Barc.), 1989;92:95-97.
41. Ellis, ME, Ralston, WS, The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome, Ann. Rheum. Dis., 1983;42:168-170.
42. Hunder, GG, Bloch, DA, Michel, BA, Stevens, MB, Arend, WP, Calabrese, LH, Edworthy, SM, Fauci, AS, Leavitt, RY, Lie, JT, Lightfoot, RW, Masi, AT, McShane, DJ, Mills, JA, Wallace, SL, Zvaifler, NJ, The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis Rheum., 1990;33:1122-1128.
43. Healey, LA, Long-term follow-up of polymyalgia rheumatica: evidence for synovitis, Semin. Arthritis Rheum., 1984;13:322-328.
44. Achkar, AA, Lie, JT, Hunder, GG, O’Fallon, WM, Gabriel, SE, How does previous corticosteroid treatment affect the biopsy findings of giant cell (temporal) arteritis? Ann. Intern. Med., 1994;120; 987-992.
45. González-Gay, MA, Blanco, R, Rodríguez-Valverde, V, Martínez-Taboada, VM, Delgado-Rodríguez, M, Figueroa, M, Uriarte, E, Permanent visual loss and cerebrovascular accidents in giant cell arteritis, Arthritis Rheum., 1998;41:1497-1504.
46. Delecoeuillerie, G, Joly, P, Cohen de Lara, A, Paolaggi, JB, Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients), Ann. Rheum. Dis., 1988;47:733-739.
47. Save-Söderbergh, J, Malmvall, BE, Andersson, R, Bengtsson, BA, Giant cell arteritis as a cause of death, JAMA, 1986;255:493-496.